{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:02:31Z","timestamp":1792598551676,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011324","name":"Qingdao University","doi-asserted-by":"publisher","award":["QDFY+X2019023"],"award-info":[{"award-number":["QDFY+X2019023"]}],"id":[{"id":"10.13039\/501100011324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.prp.2022.153960","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T11:44:42Z","timestamp":1653651882000},"page":"153960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Analysis of clinicopathological and molecular features of ELOC(TCEB1)-mutant renal cell carcinoma"],"prefix":"10.1016","volume":"235","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2022.153960_bib1","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.ajpath.2012.08.005","article-title":"A 12-gene expression signature is associated with aggressive histological in prostate cancer: SEC14L1 and ELOC(TCEB1) genes are potential markers of progression","volume":"181","author":"Agell","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2022.153960_bib2","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.7660129","article-title":"Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II","volume":"269","author":"Aso","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.prp.2022.153960_bib3","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1073\/pnas.0601638103","article-title":"Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase","volume":"103","author":"Bullock","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2022.153960_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.prp.2022.153960_bib5","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein","volume":"275","author":"Cockman","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2022.153960_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.euf.2019.11.013","article-title":"Putative drivers of aggressiveness in ELOC(TCEB1)-mutant renal cell carcinoma: an emerging entity with variable clinical course","volume":"7","author":"DiNatale","year":"2021","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.prp.2022.153960_bib7","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","article-title":"Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients","volume":"38","author":"Gill","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153960_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/modpathol.2015.6","article-title":"ELOC(TCEB1)-mutated renal cell carcinoma: a distinct genomic and morphological subtype","volume":"28","author":"Hakimi","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2022.153960_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ijc.23916","article-title":"ELOC(TCEB1) promotes invasion of prostate cancer cells","volume":"124","author":"Jalava","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2022.153960_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000108296","article-title":"Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas","volume":"118","author":"Medendorp","year":"2007","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.prp.2022.153960_bib11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/PAS.0000000000001255","article-title":"Genetic underpinnings of renal cell carcinoma with fibromyomatous stroma","volume":"43","author":"Parilla","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153960_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PAS.0b013e31825ec16f","article-title":"Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome","volume":"37","author":"Sanz-Ortega","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153960_bib13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ng.2699","article-title":"Integrated molecular analysis of clear-cell renal cell carcinoma","volume":"45","author":"Sato","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2022.153960_bib14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","article-title":"\u201cRenal Cell Carcinoma With Fibromyomatous Stroma\u201d Harbor Somatic Mutations of TSC1, TSC2, MTOR, and\/or ELOC (ELOC(TCEB1)): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity","volume":"44","author":"Shah","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2022.153960_bib15","first-page":"995","article-title":"Simultaneous double primary clear cell carcinomas of liver and kidney: a case report and review of literature","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.prp.2022.153960_bib16","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1038\/s41388-021-01900-8","article-title":"NF-kappaB-activated SPRY4-IT1 promotes cancer cell metastasis by downregulating ELOC(TCEB1) mRNA via Staufen1-mediated mRNA decay","volume":"40","author":"Zhao","year":"2021","journal-title":"Oncogene"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:52:20Z","timestamp":1759733540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822002047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":16,"alternative-id":["S0344033822002047"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153960","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of clinicopathological and molecular features of ELOC(TCEB1)-mutant renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153960"}}